Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

被引:14
|
作者
Perumalsamy, Sangeetha [1 ]
Huri, Hasniza Zaman [1 ]
Abdullah, Bashar Mudhaffar [2 ]
Mazlan, Othman [1 ]
Ahmad, Wan Azman Wan [3 ]
Vethakkan, Shireene Ratna D. B. [4 ]
机构
[1] Univ Malaya, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kuala Lumpur 50603, Malaysia
[2] Al Rafidain Univ Coll, Dept Med Labs Tech, Baghdad, Iraq
[3] Univ Malaya, Fac Med, Dept Med, Cardiol Unit, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Fac Med, Dept Med, Endocrinol Unit, Kuala Lumpur 50603, Malaysia
关键词
insulin resistance; type 2 diabetes mellitus; atherosclerosis; endothelial dysfunction; coronary artery disease; genetic markers; single nucleotide polymorphisms; GENOME-WIDE ASSOCIATION; CD36; GENE; METABOLIC SYNDROME; SERUM-LEVELS; POLYMORPHISM; INTERLEUKIN-18; RISK; VARIANTS; OBESITY; LOCUS;
D O I
10.3390/metabo13030427
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion on a background of insulin resistance (IR). IR and T2DM are associated with atherosclerotic coronary artery disease (CAD). The mechanisms of IR and atherosclerosis are known to share similar genetic and environmental roots. Endothelial dysfunction (ED) detected at the earliest stages of IR might be the origin of atherosclerosis progression. ED influences the secretion of pro-inflammatory cytokines and their encoding genes. The genes and their single nucleotide polymorphisms (SNPs) act as potential genetic markers of IR and atherosclerosis. This review focuses on the link between IR, T2DM, atherosclerosis, CAD, and the potential genetic markers CHI3L1, CD36, LEPR, RETN, IL-18, RBP-4, and RARRES2 genes.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
    Ikmal, Sharifah Intan Qhadijah Syed
    Huri, Hasniza Zaman
    Vethakkan, Shireene Ratna
    Ahmad, Wan Azman Wan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [2] Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
    Genkel, V. V.
    Salashenko, A. O.
    Shamaeva, T. N.
    Sumerkina, V. A.
    Nikushkina, K., V
    Shaposhnik, I. I.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (10) : 54 - 62
  • [3] Diffuse atherosclerosis in type 2 diabetes mellitus with coronary artery disease
    Watanabe, Y
    Nakagawa, S
    Hirotani, T
    Atsumi, Y
    Kameda, T
    Matsuoka, K
    DIABETES, 2000, 49 : A151 - A151
  • [4] Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
    Gerstein, Hertzel C.
    Ratner, Robert E.
    Cannon, Christopher P.
    Serruys, Patrick W.
    Garcia-Garcia, Hector M.
    van Es, Gerrit-Anne
    Kolatkar, Nikheel S.
    Kravitz, Barbara G.
    Miller, Diane M.
    Huang, Chun
    Fitzgerald, Peter J.
    Nesto, Richard W.
    CIRCULATION, 2010, 121 (10) : 1176 - 1187
  • [5] Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus
    Matsumoto, Kazunari
    Fujita, Naruhiro
    Nakamura, Kan
    Senoo, Takemasa
    Tominaga, Tan
    Ueki, Yukitaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (01) : 93 - 97
  • [6] Relationship among Insulin Therapy, Insulin Resistance, and Severe Coronary Artery Disease in Type 2 Diabetes Mellitus
    Song, Jing
    Xia, Xinyi
    Lu, Ye
    Wan, Jing
    Chen, Haibing
    Yin, Jun
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2022, 2022
  • [7] Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
    van Zuydam, Natalie R.
    Ladenvall, Claes
    Voight, Benjamin F.
    Strawbridge, Rona J.
    Fernandez-Tajes, Juan
    Rayner, N. William
    Robertson, Neil R.
    Mahajan, Anubha
    Vlachopoulou, Efthymia
    Goel, Anuj
    Kleber, Marcus E.
    Nelson, Christopher P.
    Kwee, Lydia Coulter
    Esko, Tonu
    Mihailov, Evelin
    Magi, Reedik
    Milani, Lili
    Fischer, Krista
    Kanoni, Stavroula
    Kumar, Jitender
    Song, Ci
    Hartiala, Jaana A.
    Pedersen, Nancy L.
    Perola, Markus
    Gieger, Christian
    Peters, Annette
    Qu, Liming
    Willems, Sara M.
    Doney, Alex S. F.
    Morris, Andrew D.
    Zheng, Yan
    Sesti, Giorgio
    Hu, Frank B.
    Qi, Lu
    Laakso, Markku
    Thorsteinsdottir, Unnur
    Grallert, Harald
    van Duijn, Cornelia
    Reilly, Muredach P.
    Ingelsson, Erik
    Deloukas, Panos
    Kathiresan, Sek
    Metspalu, Andres
    Shah, Svati H.
    Sinisalo, Juha
    Salomaa, Veikko
    Hamsten, Anders
    Samani, Nilesh J.
    Maerz, Winfried
    Hazen, Stanley L.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (06): : 640 - 648
  • [8] THE ASSOCIATION OF CIRCULATING MICRORNA-126 WITH INFLAMMATION AND INSULIN RESISTANCE IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS
    Serik, S.
    Mavrycheva, N.
    Riabukha, V.
    Malko, V.
    Bondar, T.
    Chenchik, T.
    ATHEROSCLEROSIS, 2023, 379 : S139 - S139
  • [9] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [10] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180